| Advantages | They maintain essential disease characteristics, such as genetic alterations and protein expression patterns, establishing them as robust platforms for liver cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Liver |
| Disease | Hepatocellular carcinoma |
| Organoid Characterization | Hepatocellular carcinoma organoids demonstrate high pathological fidelity to tumor tissues, with expression of key markers including AFP, CK19, EpCAM, and HepPar1. |
| Applications | Their capacity to preserve tumor heterogeneity and model the tumor microenvironment (TME) supports detailed investigations into disease mechanisms and treatment efficacy. These physiologically relevant organoids are key tools for advancing precision medicine and enabling the discovery of novel liver cancer therapies. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.